First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device

Figure 3

Graphic representation of end-organ perfusion as a function of the Aortix™ device speed in our patient, demonstrating titration of the device speed leads to persistent improvement in biomarker levels. (a) The relationship between serum creatinine and Aortix™ device speed over time. (b) The relationship between serum blood urea nitrogen and Aortix™ device speed over time. (c) The relationship between serum aspartate aminotransferase and Aortix™ device speed over time. (d) The relationship between serum alanine aminotransferase and Aortix™ device speed over time. Refer to Table 1 for numerical representation. AST = aspartate aminotransferase; ALT = alanine aminotransferase; BUN = blood urea nitrogen; hr = hours; rpm = rotations per minute.

(a)

(b)

(c)

(d)